GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CanBas Co Ltd (TSE:4575) » Definitions » Policy Acquisition Expense

CanBas Co (TSE:4575) Policy Acquisition Expense


View and export this data going back to 2009. Start your Free Trial

What is CanBas Co Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


CanBas Co (TSE:4575) Business Description

Industry
Traded in Other Exchanges
N/A
Address
9 Toriyoko-cho, Shizuoka, JPN, 410-0891
CanBas Co Ltd focuses on the discovery and development of novel oncology drugs targeting the cell cycle. Its product, CBP501 the anticancer drug candidate is a modified synthetic peptide which enhances the efficacy of cisplatin without adding toxicity.